Recombinant Mouse FGL2 HA-tag Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 10691-FL

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
10691-FL-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

NS0

Accession #

P12804.1

Conjugate

Unconjugated

Applications

Bioactivity

View all FGL2 Proteins and Enzymes »

Product Specifications

Source

Mouse myeloma cell line, NS0-derived mouse FGL2 protein
Hemagglutinin Tag
(YPYDVPDYA)		 Mouse FGL2
(Val20-Pro432)
Accession # P12804.1
N-terminus C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Tyr of HA-tag and Asp 31

Predicted Molecular Mass

48 kDa

SDS-PAGE

61-72 kDa, under reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Mouse Fc gamma RIIB/CD32b  (Catalog # 1460-CD) is immobilized at 1 µg/mL (100 µL/well), Recombinant Mouse FGL2 HA-tag (Catalog # 10691-FL) binds with an ED50 of 0.1-0.8 µg/mL.

Measured by its ability to inhibit anti-CD3-induced proliferation of mouse T lymphocytes. The ED50 for this effect is 1.5-12 µg/mL.

Scientific Data Images for Recombinant Mouse FGL2 HA-tag Protein, CF

Recombinant Mouse FGL2 HA-tag Protein Binding Activity.

When Recombinant Mouse Fc gamma RIIB/CD32b (1460-CD) is immobilized at 1 µg/mL (100 µL/well), Recombinant Mouse FGL2 HA-tag (Catalog # 10691-FL) binds with an ED50 of 0.1-0.8 µg/mL.

Recombinant Mouse FGL2 HA-tag Protein SDS-PAGE.

2 μg/lane of Recombinant Mouse FGL2 HA-tag (Catalog # 10691-FL) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 61-72 kDa and 244-288 kDa, respectively.

Formulation, Preparation and Storage

10691-FL
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution Reconstitute at 250 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: FGL2

FGL2 (fibrinogen-like protein 2), also called fibroleukin, is a 64-70 kDa secreted glycoprotein of the Fibrinogen-like superfamily. It has prothrombinase activity and also promotes T regulatory (Treg) activity (1-6). The mouse FGL2 gene encodes a 439 amino acid (aa) protein that contains a 23 aa signal sequence and a 416 aa mature sequence with an N-terminal coiled-coil region and a C-terminal fibrinogen homology domain or FRED (1, 2). A 260-280 kDa FGL2 complex is thought to be a tetramer formed by covalent disulfide linkage of dimers that are associated via coiled-coil interactions (2, 3). Mature mouse FGL2 shares 79% and  91% homology with human and rat FGL2 respectively. FGL2 appears to have two modes of action. One mode involves its prothrombinase activity, which requires calcium and acidic phospholipids (4). This mode is thought to be active during hepatitis viral infections when FGL2, produced by macrophages in response to IFN-gamma, induces hepatic apoptosis and fibrin deposition (7). In addition, FGL2 produced by endothelial cells in response to TNF-alpha within cardiac xenografts or allografts promotes coagulation during acute vascular rejection (7-9). A second mode of action involves soluble (not phospholipid-associated) FGL2 and is independent of prothrombinase activity (2). Soluble FGL2 is required for Treg function, and directly suppresses DC, T, and B cell immune reactivity; consequently, some FGL2-deficent mice develop autoimmune glomerulonephritis (5, 6). In vitro, soluble FGL2 can skew T cell polarization toward Th2 and inhibit proliferation of stimulated T cells and maturation of DC (6). In pregnancy, fetal trophoblast cells secrete FGL2. The immune suppressive mode of FGL2 may prevent early fetal loss; however, the procoagulant mode is thought to mediate infection-triggered abortion (10). In the central nervous system (CNS), FGL2 was shown to be highly expressed in glioma stem cells and primary glioblastoma cells and may serve as a critical immune oncology target (11).

References

  1. Koyama, T. et al. (1987) Proc. Natl. Acad. Sci. USA 84:1609.
  2. Marazzi, S. et al. (1998) J. Immunol.161:138.
  3. Olson, G. E. et al. (2004) J. Biol. Chem. 279:51266.
  4. Chan, C. W. Y. et al. (2002) J. Immunol. 168:5170.
  5. Shalev, I. et al. (2008) J. Immunol.180:249.
  6. Chan, C. W. Y. et al. (2003) J. Immunol. 170:4036.
  7. Liu, M. et al. (2006) J. Immunol. 176:7028.
  8. Mendicino, M. et al. (2005) Circulation 112:248.
  9. Ning, Q. et al. (2005) J. Immunol. 174:7403.
  10. Clark, D. A. et al. (2004) Mol. Hum. Reprod. 10:99.
  11. Yan, J. et al. (2019) Nat Commun. 10:448.

Long Name

Fibrinogen-like 2

Alternate Names

Fibroleukin, T49

Entrez Gene IDs

10875 (Human); 14190 (Mouse); 84586 (Rat); 102123631 (Cynomolgus Monkey)

Gene Symbol

FGL2

UniProt

P12804.1

Additional FGL2 Products

Product Documents for Recombinant Mouse FGL2 HA-tag Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Mouse FGL2 HA-tag Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.